BioCentury
ARTICLE | Management Tracks

Cox to head digital health at Pfizer

Plus Stegmeier joins Curie Bio and updates from Actinium, Lexeo and more

November 2, 2022 10:28 PM UTC

Edward Cox said on LinkedIn that he has joined Pfizer Inc. (NYSE:PFE) as head & general manager of digital health & medicines. Cox was EVP strategic alliances & global head of digital medicine at Eversana Life Science Services LLC and CEO at Dthera Sciences. He is a member of the leadership council at CNS Summit and board member at the non-profit Decentralized Trials & Research Alliance. 

Frank Stegmeier will become CSO partner at Curie.Bio, a seed stage venture firm that is expected to launch by year-end. Stegmeier recently transitioned from CSO at KSQ Therapeutics Inc. to a board position; he was succeeded as CSO by SVP of Immunobiology Micah Benson in September. ...